Company Analysis
Sign in

BioCryst Pharmaceuticals, Inc. (BCRX)

Nasdaq: BCRX · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 1995
Full chart Alerts Compare
Grade6.1
◀ Past 6.3● Present 5.6▶ Future 6.4
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 26, 2026Feb 25, 2025Feb 27, 2024Feb 27, 2023Feb 28, 2022Mar 1, 2021Mar 13, 2020Mar 14, 2019Mar 12, 2018Feb 27, 2017
Revenue874,837450,712331,412270,827157,17017,81248,83520,65325,18626,353
Cost of revenue19,07512,2694,4816,4087,2291,5503,726·1,1422,297
Research and development166,126174,638216,566253,297208,808122,964107,06884,88866,96261,008
Selling, general and administrative348,647266,348r214,074r159,371118,81867,92937,12129,51413,93311,253
Total costs and expenses533,848453,255435,121419,262334,890192,569148,290114,87382,59774,960
Operating income340,989-2,543-103,709-148,435-177,720-174,757-99,455-94,220-57,411-48,607
Interest expense78,87298,516108,23999,09259,29414,50111,8929,1768,5656,487
Total non-operating income (expense)-73,598-84,411-122,520-95,948······
Income before income taxes267,391-86,954-226,229-244,383-181,809-182,814-108,897···
Income tax expense3,5301,9273102,7332,25300000
Net income263,861-88,881-226,539-247,116-184,062-182,814-108,897-101,252-65,782-55,144
Earnings per share, basic1.26-0.43-1.18-1.33-1.03-1.09····
Earnings per share, diluted1.21-0.43-1.18-1.33-1.03-1.09····
Earnings per share, basic and diluted····-1,030.00-1,090.00r-940.00r-0.98-0.78-0.75
Weighted average shares, basic209,893206,696192,198185,908179,117167,267····
Weighted average shares, diluted218,581206,696192,198185,908179,117167,267115,600103,18584,45173,699
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton BCRX · research, not advice